Intravenous Temsirolimus in Cancer Patients: Clinical Pharmacology and Dosing Considerations
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference31 articles.
1. Torisel [package insert],2008
2. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma;Hudes;N Engl J Med,2008
3. Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma;Hess;J Clin Oncol,2009
4. Rapamycin for immunosuppression in organ allografting;Calne;Lancet,1989
5. The TOR pathway: a target for cancer therapy;Bjornsti;Nat Rev Cancer,2004
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Targeting ageing with rapamycin and its derivatives in humans: a systematic review;The Lancet Healthy Longevity;2024-02
2. Why Is Rapamycin Not a Rapalog?;Gerontology;2023
3. Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021;Journal of Hematology & Oncology;2022-10-08
4. Rapamycin golden jubilee and still the miraculous drug: a potent immunosuppressant, antitumor, rejuvenative agent, and potential contributor in COVID-19 treatment;Bioresources and Bioprocessing;2022-06-13
5. Evidence for Bell-Shaped Dose-Response Emetic Effects of Temsirolimus and Analogs: The Broad-Spectrum Antiemetic Efficacy of a Large Dose of Temsirolimus Against Diverse Emetogens in the Least Shrew (Cryptotis parva);Frontiers in Pharmacology;2022-04-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3